ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,706, issued on Aug. 25, was assigned to PHARMA MAR S.A. (Madrid).
"Methods of treating small cell lung cancer with lurbinectedin formulations" was invented by Carmen Kahatt (Madrid), Jose Maria Fernandez (Madrid), Salvador Fudio (Madrid), Arturo Soto (Madrid) and Pilar Lardelli (Madrid).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods for the treatment of SCLC patients by administering therapeutic amounts of lurbinectedin by intravenous infusion. Also provided are methods of treating cancer by administering lurbinectedin in combination with other anticancer drugs, in particular topoisomerase inhibitors. The invention further relate...